Spyre Therapeutics Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Analysis

Spyre Therapeutics, Inc. (SYRE)

73.65 -0.40 (-0.54%) USD | NASDAQ | May 26, 16:00

73.15 -0.50 (-0.68%) After-Hours: 05:56

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for SYRE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

Tyra Biosciences, Inc.	Upgrade
Cogent Biosciences, Inc.	Upgrade
Revolution Medicines, Inc.	Upgrade
Apellis Pharmaceuticals, Inc. (DELISTED)	Upgrade
Replimune Group, Inc.	Upgrade